Literature DB >> 22575810

Extraskeletal Ewing's sarcoma presenting as a posterior mediastinal mass.

Ahmet Mesrur Halefoglu1.   

Abstract

The Ewing's sarcoma family of tumors is an uncommon group of malignant neoplasms that may be located in both skeletal and extraskeletal regions. Extraskeletal Ewing's sarcoma (EES) is quite rare and predominantly involves the soft tissues of the trunk or the extremities. Herein, we report the case of a 19-year-old female patient who complained of left arm pain. Simple chest radiography revealed an opacity occupying almost the entire left hemithorax. Diagnostic imaging techniques demonstrated a solid contrast-enhanced mass in the posterior mediastinum. There was an evident mediastinal shift, and the left lung was collapsed. Even though lymphoma was considered as an initial diagnosis, a biopsy was taken and its histopathological analysis revealed EES. In the literature, there have been only a few case reports of ESS located in the mediastinum. We conclude that, although this is an unusual location, EES should be contemplated in the differential diagnosis of mediastinal masses.
Copyright © 2012 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22575810     DOI: 10.1016/j.arbres.2012.02.020

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  3 in total

1.  Primary extraosseous Ewing sarcoma of the lung in children.

Authors:  Nidal Alsit; Clara Fernandez; Jean Luc Michel; Linda Sakhri; Audrey Derouet; Augustin Pirvu
Journal:  Ecancermedicalscience       Date:  2013-04-30

Review 2.  Mesenchymal tumours of the mediastinum--part II.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

3.  Extraskeletal Ewing's sarcoma/primitive neuroectodermal tumor of the mediastinum: Significant response to chemoradiotherapy.

Authors:  Min Liu; Bailong Liu; Lihua Dong; Tao Han; Lei Zhang
Journal:  Oncol Lett       Date:  2014-12-10       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.